The pharmacy benefits manager reported revenues of $24.7 billion in the third quarter ended Sept. 30, down from $25.4 billion in the same period last year. Express Scripts dispensed fewer prescriptions in the most recent quarter compared to the same period last year, from 347 million to 344 million.
The decrease comes as Express Scripts is slated to lose its largest client, Anthem, by 2019. The split echoes an ongoing legal battle between the two parties.
Overall, Express Scripts ended the third quarter of this year with net income of $841.7 million compared to $722.9 million in the same period last year.
Effective Oct. 25, the PBM also appointed a new CFO: James Havel.
More articles on supply chain:
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Baxter expects $70M revenue loss from Hurricane Maria
Amazon rolls out 2-day Prime shipping for businesses
